J&J steadily rebuilds its US OTC business

22 July 2013 - Deborah Wilkes


A "reliable and consistent supply" of 75% of Johnson & Johnson's recalled OTC products would be available in the US by the end of 2013, according to Sandra Peterson, Johnson & Johnson's group worldwide chairman with responsibility for the Consumer Group of Companies.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: